{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T02:08:25Z","timestamp":1758593305150,"version":"3.44.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"am","delay-in-days":396,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.neurol.2021.07.021","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T14:05:10Z","timestamp":1634825110000},"page":"185-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of stroke in patients on antithrombotic therapy: Practical issues in the era of direct oral anticoagulants"],"prefix":"10.1016","volume":"178","author":[{"given":"I.","family":"Sibon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.S.","family":"Liegey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10152","key":"10.1016\/j.neurol.2021.07.021_bib0500","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.neurol.2021.07.021_bib0505","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","article-title":"Effects of aspirin for primary prevention in persons with diabetes mellitus","volume":"379","author":"Bowman","year":"2018","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.neurol.2021.07.021_bib0510","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.neurol.2021.07.021_bib0515","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.neurol.2021.07.021_bib0520","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1161\/STROKEAHA.117.017981","article-title":"Emergency coagulation assessment during treatment with direct oral anticoagulants: limitations and solutions","volume":"48","author":"Ebner","year":"2017","journal-title":"Stroke"},{"issue":"19","key":"10.1016\/j.neurol.2021.07.021_bib0525","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1212\/WNL.0000000000002657","article-title":"Aspirin resistance is associated with increased stroke severity and infarct volume","volume":"86","author":"Oh","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2021.07.021_bib0530","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1001\/jamaneurol.2013.601","article-title":"Association of aspirin resistance with increased stroke severity and infarct size","volume":"70","author":"Zheng","year":"2013","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2021.07.021_bib0535","article-title":"Downstream microvascular thrombosis in cortical venules is an early response to proximal cerebral arterial occlusion","volume":"7","author":"Desilles","year":"2018","journal-title":"J Am Heart Assoc [Internet]"},{"issue":"9843","key":"10.1016\/j.neurol.2021.07.021_bib0540","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(12)60949-0","article-title":"Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial","volume":"380","author":"Zinkstok","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.neurol.2021.07.021_bib0545","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamaneurol.2015.3106","article-title":"Risks and benefits associated with prestroke antiplatelet therapy among patients with acute ischemic stroke treated with intravenous tissue plasminogen activator","volume":"73","author":"Xian","year":"2016","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2021.07.021_bib0550","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00415-017-8520-1","article-title":"Antiplatelet pretreatment and outcomes in intravenous thrombolysis for stroke: a systematic review and meta-analysis","volume":"264","author":"Tsivgoulis","year":"2017","journal-title":"J Neurol"},{"issue":"11","key":"10.1016\/j.neurol.2021.07.021_bib0555","doi-asserted-by":"crossref","first-page":"e1067","DOI":"10.1212\/WNL.0000000000006168","article-title":"Dual antiplatelet therapy pretreatment in IV thrombolysis for acute ischemic stroke","volume":"91","author":"Tsivgoulis","year":"2018","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurol.2021.07.021_bib0560","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5853\/jos.2016.00185","article-title":"Prestroke antiplatelet effect on symptomatic intracranial hemorrhage and functional outcome in intravenous thrombolysis","volume":"18","author":"Choi","year":"2016","journal-title":"J Stroke"},{"issue":"5","key":"10.1016\/j.neurol.2021.07.021_bib0565","doi-asserted-by":"crossref","first-page":"e003242","DOI":"10.1161\/JAHA.116.003242","article-title":"Intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy: a systematic review and meta-analysis of 19 studies","volume":"5","author":"Luo","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.neurol.2021.07.021_bib0570","doi-asserted-by":"crossref","first-page":"e657","DOI":"10.1212\/WNL.0000000000008961","article-title":"Safety and efficacy of dual antiplatelet pretreatment in patients with ischemic stroke treated with IV thrombolysis: a systematic review and meta-analysis","volume":"94","author":"Malhotra","year":"2020","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurol.2021.07.021_bib0575","doi-asserted-by":"crossref","first-page":"NP71","DOI":"10.1177\/1747493016648968","article-title":"Symptomatic intracerebral and systemic hemorrhage after stroke thrombolysis in patients taking ticagrelor","volume":"11","author":"Lo","year":"2016","journal-title":"Int J Stroke"},{"issue":"12","key":"10.1016\/j.neurol.2021.07.021_bib0580","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3390\/jcm7120518","article-title":"Prior use of antiplatelet therapy and outcomes after endovascular therapy in acute ischemic stroke due to large vessel occlusion: a single-center experience","volume":"7","author":"Merlino","year":"2018","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.neurol.2021.07.021_bib0585","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/neurintsurg-2017-013532","article-title":"Antiplatelet pretreatment and outcomes following mechanical thrombectomy for emergent large vessel occlusion strokes","volume":"10","author":"Pandhi","year":"2018","journal-title":"J Neurointerv Surg"},{"issue":"4","key":"10.1016\/j.neurol.2021.07.021_bib0590","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/1747493016677842","article-title":"Does prior antiplatelet treatment improve functional outcome after intra-arterial treatment for acute ischemic stroke?","volume":"12","author":"Mulder","year":"2017","journal-title":"Int J Stroke"},{"issue":"6","key":"10.1016\/j.neurol.2021.07.021_bib0595","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jacc.2016.11.050","article-title":"Enteric coating and aspirin nonresponsiveness in patients with Type\u00a02\u00a0diabetes mellitus","volume":"69","author":"Bhatt","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.neurol.2021.07.021_bib0600","doi-asserted-by":"crossref","first-page":"d2690","DOI":"10.1136\/bmj.d2690","article-title":"Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study","volume":"342","author":"Charlot","year":"2011","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.neurol.2021.07.021_bib0605","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1538-7836.2012.04723.x","article-title":"The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes","volume":"10","author":"Rocca","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.neurol.2021.07.021_bib0610","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1111\/j.1538-7836.2011.04482.x","article-title":"Genetic determinants of platelet reactivity during acetylsalicylic acid therapy in diabetic patients: evaluation of 27 polymorphisms within candidate genes","volume":"9","author":"Postula","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"10145","key":"10.1016\/j.neurol.2021.07.021_bib0615","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(18)31133-4","article-title":"Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials","volume":"392","author":"Rothwell","year":"2018","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.neurol.2021.07.021_bib0620","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1161\/STROKEAHA.117.017895","article-title":"Antiplatelet regimen for patients with breakthrough strokes while on aspirin: a systematic review and meta-analysis","volume":"48","author":"Lee","year":"2017","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.neurol.2021.07.021_bib0625","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1105335","article-title":"Stenting versus aggressive medical therapy for intracranial arterial stenosis","volume":"365","author":"Chimowitz","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.neurol.2021.07.021_bib0630","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.neurol.2021.07.021_bib0635","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.neurol.2021.07.021_bib0640","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJMoa1204133","article-title":"Effects of clopidogrel added to aspirin in patients with recent lacunar stroke","volume":"367","author":"SPS3 Investigators","year":"2012","journal-title":"N Engl J Med"},{"issue":"9431","key":"10.1016\/j.neurol.2021.07.021_bib0645","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.neurol.2021.07.021_bib0650","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.neurol.2021.07.021_bib0655","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"378","author":"Hart","year":"2018","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.neurol.2021.07.021_bib0660","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source","volume":"380","author":"Diener","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.neurol.2021.07.021_bib0665","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/1747493018799981","article-title":"The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods","volume":"14","author":"Kamel","year":"2019","journal-title":"Int J Stroke"},{"issue":"14","key":"10.1016\/j.neurol.2021.07.021_bib0670","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.neurol.2021.07.021_bib0675","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1538-7836.2005.01351.x","article-title":"Aspirin resistance: position paper of the Working Group on Aspirin Resistance","volume":"3","author":"Michelson","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"14","key":"10.1016\/j.neurol.2021.07.021_bib0680","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.neurol.2021.07.021_bib0685","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/eurheartj\/ehm226","article-title":"A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease","volume":"28","author":"Lordkipanidz\u00e9","year":"2007","journal-title":"Eur Heart J"},{"issue":"3\u20134","key":"10.1016\/j.neurol.2021.07.021_bib0690","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000438722","article-title":"Interest of antiplatelet drug testing after an acute ischemic stroke","volume":"74","author":"Coignion","year":"2015","journal-title":"Eur Neurol"},{"key":"10.1016\/j.neurol.2021.07.021_bib0695","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainresbull.2018.07.004","article-title":"Aspirin resistance predicts unfavorable functional outcome in acute ischemic stroke patients","volume":"142","author":"Wang","year":"2018","journal-title":"Brain Res Bull"},{"issue":"7","key":"10.1016\/j.neurol.2021.07.021_bib0700","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/09537100802317918","article-title":"The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence","volume":"19","author":"van Werkum","year":"2008","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.neurol.2021.07.021_bib0705","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1603060","article-title":"Ticagrelor versus aspirin in acute stroke or transient ischemic attack","volume":"375","author":"Johnston","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.neurol.2021.07.021_bib0710","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1474-4422(17)30038-8","article-title":"Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial","volume":"16","author":"Amarenco","year":"2017","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2021.07.021_bib0715","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1916870","article-title":"Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA","volume":"383","author":"Johnston","year":"2020","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.neurol.2021.07.021_bib0720","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jama.280.22.1930","article-title":"Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials","volume":"280","author":"He","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.neurol.2021.07.021_bib0725","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archneur.57.3.326","article-title":"Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses","volume":"57","author":"Hart","year":"2000","journal-title":"Arch Neurol"},{"issue":"20","key":"10.1016\/j.neurol.2021.07.021_bib0730","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.neurol.2021.07.021_bib0735","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1001\/jamaneurol.2013.98","article-title":"Predictors of hematoma volume in deep and lobar supratentorial intracerebral hemorrhage","volume":"70","author":"Falcone","year":"2013","journal-title":"JAMA Neurol"},{"issue":"10","key":"10.1016\/j.neurol.2021.07.021_bib0740","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(18)30253-9","article-title":"Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data","volume":"17","author":"Al-Shahi Salman","year":"2018","journal-title":"Lancet Neurol"},{"issue":"10038","key":"10.1016\/j.neurol.2021.07.021_bib0745","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","article-title":"Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial","volume":"387","author":"Baharoglu","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.neurol.2021.07.021_bib0750","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12028-019-00899-x","article-title":"The role of desmopressin on hematoma expansion in patients with mild traumatic brain injury prescribed pre-injury antiplatelet medications","volume":"33","author":"Barletta","year":"2020","journal-title":"Neurocrit Care"},{"issue":"12","key":"10.1016\/j.neurol.2021.07.021_bib0755","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/CCM.0000000000004021","article-title":"Retrospective assessment of desmopressin effectiveness and safety in patients with antiplatelet-associated intracranial hemorrhage","volume":"47","author":"Feldman","year":"2019","journal-title":"Crit Care Med"},{"issue":"10135","key":"10.1016\/j.neurol.2021.07.021_bib0760","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","article-title":"Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial","volume":"391","author":"Sprigg","year":"2018","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.neurol.2021.07.021_bib0765","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","article-title":"Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association","volume":"46","author":"Hemphill","year":"2015","journal-title":"Stroke"},{"issue":"19","key":"10.1016\/j.neurol.2021.07.021_bib0770","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa1901778","article-title":"Antibody-based ticagrelor reversal agent in healthy volunteers","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.neurol.2021.07.021_bib0775","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1212\/WNL.0000000000005742","article-title":"Restarting antiplatelet therapy after spontaneous intracerebral hemorrhage: functional outcomes","volume":"91","author":"Chen","year":"2018","journal-title":"Neurology"},{"issue":"10191","key":"10.1016\/j.neurol.2021.07.021_bib0780","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1016\/S0140-6736(19)30840-2","article-title":"Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial","volume":"393","year":"2019","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.neurol.2021.07.021_bib0785","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1212\/01.wnl.0000435298.80023.7a","article-title":"Cortical superficial siderosis and intracerebral hemorrhage risk in cerebral amyloid angiopathy","volume":"81","author":"Charidimou","year":"2013","journal-title":"Neurology"},{"issue":"5\u20136","key":"10.1016\/j.neurol.2021.07.021_bib0790","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000343655","article-title":"Oral anticoagulants--a frequent challenge for the emergency management of acute ischemic stroke","volume":"34","author":"Rizos","year":"2012","journal-title":"Cerebrovasc Dis"},{"issue":"10","key":"10.1016\/j.neurol.2021.07.021_bib0795","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jama.2017.1371","article-title":"Association of preceding antithrombotic treatment with acute ischemic stroke severity and in-hospital outcomes among patients with atrial fibrillation","volume":"317","author":"Xian","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.neurol.2021.07.021_bib0800","doi-asserted-by":"crossref","first-page":"e010593","DOI":"10.1161\/JAHA.118.010593","article-title":"Prior anticoagulation and short- or long-term clinical outcomes in ischemic stroke or transient ischemic attack patients with nonvalvular atrial fibrillation","volume":"8","author":"Tokunaga","year":"2019","journal-title":"J Am Heart Assoc [Internet]"},{"issue":"17","key":"10.1016\/j.neurol.2021.07.021_bib0805","doi-asserted-by":"crossref","first-page":"e009507","DOI":"10.1161\/JAHA.118.009507","article-title":"Prior direct oral anticoagulant therapy is related to small infarct volume and no major artery occlusion in patients with stroke and non-valvular atrial fibrillation","volume":"7","author":"Sakamoto","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.neurol.2021.07.021_bib0810","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/STROKEAHA.119.026426","article-title":"Safety of intravenous thrombolysis among patients taking direct oral anticoagulants: a systematic review and meta-analysis","volume":"51","author":"Shahjouei","year":"2020","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.neurol.2021.07.021_bib0815","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/ene.13582","article-title":"Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants","volume":"25","author":"Touz\u00e9","year":"2018","journal-title":"Eur J Neurol"},{"issue":"24","key":"10.1016\/j.neurol.2021.07.021_bib0820","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1001\/jama.2012.6756","article-title":"Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator","volume":"307","author":"Xian","year":"2012","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.neurol.2021.07.021_bib0825","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/CIRCULATIONAHA.116.023940","article-title":"Use of intravenous recombinant tissue plasminogen activator in patients with acute ischemic stroke who take non-vitamin K antagonist oral anticoagulants before stroke","volume":"135","author":"Xian","year":"2017","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.neurol.2021.07.021_bib0830","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1161\/01.STR.0000035735.49388.4A","article-title":"Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials","volume":"33","author":"Hart","year":"2002","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.neurol.2021.07.021_bib0835","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1161\/STROKEAHA.118.020890","article-title":"Reversal of vitamin K antagonist therapy before thrombolysis for acute ischemic stroke","volume":"49","author":"Chausson","year":"2018","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.neurol.2021.07.021_bib0840","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal - full cohort analysis","volume":"377","author":"Pollack","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.neurol.2021.07.021_bib0845","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMoa1607887","article-title":"Andexanet Alfa for acute major bleeding associated with factor Xa inhibitors","volume":"375","author":"Connolly","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.neurol.2021.07.021_bib0850","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/1747493017701944","article-title":"Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany \u2013 A national case collection","volume":"12","author":"Kermer","year":"2017","journal-title":"Int J Stroke"},{"issue":"3","key":"10.1016\/j.neurol.2021.07.021_bib0855","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.11.029","article-title":"Intravenous thrombolysis in acute ischemic stroke after idarucizumab reversal of dabigatran effect: analysis of the cases from Taiwan","volume":"28","author":"Fang","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"10.1016\/j.neurol.2021.07.021_bib0860","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1747493016669849","article-title":"Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: expert opinion","volume":"12","author":"Diener","year":"2017","journal-title":"Int J Stroke"},{"issue":"9","key":"10.1016\/j.neurol.2021.07.021_bib0865","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.05.004","article-title":"Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience","volume":"27","author":"\u0160a\u0148\u00e1k","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"10.1016\/j.neurol.2021.07.021_bib0870","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/STROKEAHA.119.028327","article-title":"Dabigatran reversal before intravenous tenecteplase in acute ischemic stroke","volume":"51","author":"Beharry","year":"2020","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.neurol.2021.07.021_bib0875","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.3324\/haematol.2017.183400","article-title":"Usefulness of initial plasma dabigatran concentration to predict rebound after reversal","volume":"103","author":"Gendron","year":"2018","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.neurol.2021.07.021_bib0880","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.09.019","article-title":"Adequate adherence to direct oral anticoagulant is associated with reduced ischemic stroke severity in patients with atrial fibrillation","volume":"28","author":"Yamashiro","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"21","key":"10.1016\/j.neurol.2021.07.021_bib0885","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2001123","article-title":"Endovascular thrombectomy with or without intravenous alteplase in acute stroke","volume":"382","author":"Yang","year":"2020","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.neurol.2021.07.021_bib0890","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJMoa1716405","article-title":"Tenecteplase versus alteplase before thrombectomy for ischemic stroke","volume":"378","author":"Campbell","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.neurol.2021.07.021_bib0895","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1136\/neurintsurg-2017-013714","article-title":"Safety and efficacy of mechanical thrombectomy in acute ischemic stroke of anticoagulated patients","volume":"10","author":"L\u2019Allinec","year":"2018","journal-title":"J Neurointerv Surg"},{"issue":"1","key":"10.1016\/j.neurol.2021.07.021_bib0900","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1474-4422(18)30356-9","article-title":"Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation","volume":"18","author":"Seiffge","year":"2019","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2021.07.021_bib0905","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S1474-4422(12)70092-3","article-title":"Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial","volume":"11","author":"Easton","year":"2012","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2021.07.021_bib0910","first-page":"507","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2020","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.neurol.2021.07.021_bib0915","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","article-title":"Apixaban for the treatment of venous thromboembolism associated with cancer","volume":"382","author":"Agnelli","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.neurol.2021.07.021_bib0920","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.autrev.2018.04.009","article-title":"Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis","volume":"17","author":"Dufrost","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.neurol.2021.07.021_bib0925","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/CIRCULATIONAHA.117.028513","article-title":"Efficacy and safety of the use of non-vitamin k antagonist oral anticoagulants in patients with nonvalvular atrial fibrillation and concomitant aspirin therapy: a meta-analysis of randomized trials","volume":"137","author":"Bennaghmouch","year":"2018","journal-title":"Circulation"},{"issue":"10154","key":"10.1016\/j.neurol.2021.07.021_bib0930","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0140-6736(18)31878-6","article-title":"Intracerebral haemorrhage: current approaches to acute management","volume":"392","author":"Cordonnier","year":"2018","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.neurol.2021.07.021_bib0935","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1212\/01.wnl.0000326895.58992.27","article-title":"Warfarin use leads to larger intracerebral hematomas","volume":"71","author":"Flaherty","year":"2008","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.neurol.2021.07.021_bib0940","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1001\/jamaneurol.2013.98","article-title":"Predictors of hematoma volume in deep and lobar supratentorial intracerebral hemorrhage","volume":"70","author":"Falcone","year":"2013","journal-title":"JAMA Neurol"},{"issue":"10","key":"10.1016\/j.neurol.2021.07.021_bib0945","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1161\/STROKEAHA.118.021979","article-title":"Clinical outcomes and neuroimaging profiles in nondisabled patients with anticoagulant-related intracerebral hemorrhage","volume":"49","author":"Lioutas","year":"2018","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.neurol.2021.07.021_bib0950","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S1474-4422(16)00110-1","article-title":"Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial","volume":"15","author":"Steiner","year":"2016","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2021.07.021_bib0955","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/ana.25134","article-title":"Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage","volume":"83","author":"Gerner","year":"2018","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2021.07.021_bib0960","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11239-017-1506-0","article-title":"Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis","volume":"44","author":"Brekelmans","year":"2017","journal-title":"J Thromb Thrombolysis"},{"issue":"5\u20136","key":"10.1016\/j.neurol.2021.07.021_bib0965","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1159\/000448815","article-title":"Adverse events following international normalized ratio reversal in intracerebral hemorrhage","volume":"42","author":"Laible","year":"2016","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"10.1016\/j.neurol.2021.07.021_bib0970","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13054-019-2492-8","article-title":"Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage","volume":"23","author":"Kuramatsu","year":"2019","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.neurol.2021.07.021_bib0975","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12028-017-0403-x","article-title":"Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants","volume":"27","author":"Purrucker","year":"2017","journal-title":"Neurocrit Care"},{"issue":"6","key":"10.1016\/j.neurol.2021.07.021_bib0980","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/STROKEAHA.116.016327","article-title":"Restarting anticoagulant therapy after intracranial hemorrhage: a systematic review and meta-analysis","volume":"48","author":"Murthy","year":"2017","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.neurol.2021.07.021_bib0985","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/STROKEAHA.116.014643","article-title":"Optimal timing of anticoagulant treatment after intracerebral hemorrhage in patients with atrial fibrillation","volume":"48","author":"Pennlert","year":"2017","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.neurol.2021.07.021_bib0990","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1747493018790081","article-title":"Prehospital idarucizumab prior to intravenous thrombolysis in a mobile stroke unit","volume":"14","author":"Zhao","year":"2019","journal-title":"Int J Stroke"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378721007074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378721007074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:43:31Z","timestamp":1758519811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378721007074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0035378721007074"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2021.07.021","relation":{},"ISSN":["0035-3787"],"issn-type":[{"type":"print","value":"0035-3787"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of stroke in patients on antithrombotic therapy: Practical issues in the era of direct oral anticoagulants","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2021.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}